Developing exoneural treatments for cancer, immunological, and regenerative diseases

 

Life-changing medicines through transformational science

 

CygnalImage_1500x1200.jpg

Cygnal Therapeutics is developing drugs to manipulate exoneural biology for the treatment of cancer, immunological diseases, and regenerative processes. Powered by a comprehensive, cutting-edge neurotechnology platform, we are discovering new dimensions of neural function.

Cygnal was founded by Flagship Pioneering in the VentureLabs innovation foundry, and is located in the heart of Cambridge, MA. We seek exceptional and visionary scientists to join our team.

orange.jpg
join our team.jpg
 
Final Flagship Logo_Artboard 4.png